WHO ICTRP trial
Effect of Perioperative Continuous Intravenous Infusion of Lidocaine on…
ChiCTR2100046955 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting
Key facts
| Trial ID | ChiCTR2100046955 |
|---|---|
| Public title | Effect of Perioperative Continuous Intravenous Infusion of Lidocaine on Postoperative Rapid Recovery in Patients With Primary Liver Cancer Undergoing Hepatectomy: a Prospective Randomized Controlled Trial |
| Scientific title | Effect of Perioperative Continuous Intravenous Infusion of Lidocaine on Postoperative Rapid Recovery in Patients With Primary Liver Cancer Undergoing Hepatectomy: a Prospective Randomized Controlled Trial |
| Primary sponsor | West China Hospital, Sichuan University |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Recruiting |
| Study type | Interventional study |
| Countries | China |
| Conditions | Hepatectomy |
| Interventions | Lidocaine group:1% lidocaine(1.5mg/kg) is administrated intravenously over ten minutes at the induction of general anesthesia, followed by continuous infusion of 1% lidocaine at 1.5mg/kg/h throughout the surgery. At the end of the… |
| Registration date | Jun 2, 2021 |
| Target size | Lidocaine group:130;Conventional analgesia group:130 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: